Aspire Biopharma Holdings Inc
Research Aspire Biopharma Holdings Inc (ASBP) on Bullrun: market cap USD 10.75M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerASBP
- ExchangeNASDAQ
- CountryUnited States
- SectorConsumer Cyclical
- IndustryAuto Parts
- CurrencyUSD
- Market capUSD 10.75M
- Financial periodQ2 2026
- RevenueUSD 63.10K
- Net income-USD 1.27M
- Free cash flow-USD 2.12M
- Gross margin-47.7%
Valuation Snapshot
latest market cap is USD 10.75M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 6.20K | -USD 24.48M | -USD 4.92M | -1.9% | -16.38 | USD 1.00M | USD 5.18M | -USD 6.38M |
| FY2024 | USD 0 | -USD 1.31M | -USD 265.19K | n/a | -1.9 | USD 3.63K | USD 1.27M | -USD 1.54M |
| FY2023 | USD 0 | USD 4.46M | USD 11.14K | n/a | 116.44 | USD 11.17K | USD 360.64K | -USD 487.86K |
| FY2022 | USD 0 | USD 3.34M | -USD 5.04M | n/a | -15.57 | USD 497.26K | USD 27.97K | -USD 9.94M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 10.75M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 18.66M | n/a | n/a | n/a |
| 2024 | 2024-06-28 | n/a | 464.7 | n/a | n/a |
| 2023 | 2023-12-29 | n/a | 56.9 | n/a | n/a |
| 2022 | 2022-12-30 | n/a | 358.3 | n/a | n/a |
About Aspire Biopharma Holdings Inc
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects.
Related stock research
Other Consumer Cyclical stocks
Frequently asked questions
What is Aspire Biopharma Holdings Inc's market cap?
Aspire Biopharma Holdings Inc's market capitalization is USD 10.75M.
What does Aspire Biopharma Holdings Inc do?
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain management and anti-inflammatory applications.